Navigation Links
Scientists Hot on Trail of New Antibiotics
Date:10/17/2008

Natural compounds could mean faster treatments for TB, fight other drug-resistant bacteria

FRIDAY, Oct. 17 (HealthDay News) -- Researchers believe they are close to perfecting a new class of broad-spectrum antibiotics that could counter increasingly drug-resistant bacteria, a new study says.

The new antibiotics compounds -- all of which are natural products produced by certain bacteria to battle other bacteria -- also show promise as a more effective and faster treatment for tuberculosis. One in three people worldwide carries TB, and today's antibiotics are not efficient in combating it.

The new research, published in the Oct. 17 issue of the journal Cell, is encouraging, because bacterial infectious diseases are responsible for a quarter of all deaths worldwide. For all major bacterial pathogens, strains resistant to at least one current antibiotic have arisen, according to one researcher.

"For six decades, antibiotics have been our bulwark against bacterial infectious diseases," Richard Ebright, a Howard Hughes Institute investigator at Rutgers University, said in an interview issued by the journal's publisher. "Now, this bulwark is collapsing. There is an urgent need for new antibiotic compounds and practical new targets."

The new antibiotic compounds under study are myxopyronin, corallopyronin, and ripostatin. They block the action in bacteria of RNA polymerase, an essential protein in all organisms that is necessary to transcribe the genetic instructions in DNA into RNA, which in turn directs the assembly of proteins.

"RNA polymerase has a shape reminiscent of a crab claw, with two prominent pincer-like projections," Ebright said. "Just as with a real crab claw, one pincer stays fixed and one pincer moves, opening and closing to keep DNA in place. The pincer that moves does so by rotating about a hinge. Our studies show that the three antibiotics bind to and jam this hinge." '/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists Hot on Trail of New Antibiotics
Scientists Hot on Trail of New Antibiotics
(Date:11/8/2009)...ealth Care Reform Bill ,, Critical legislatio...all Americans ,, BALTIMORE, Nov. 7 /PRNewswire...es House of Representatives passed critical health...icare for seniors and end discrimination by insura...t of affordable health coverage. ,, The Afforda...
(Date:11/7/2009)...e-USNewswire/ -- Speaker Nancy Pelosi spoke on th...ffordable Health Care for America Act. The House ... are the Speaker,s remarks. ,, "Madam Speaker,...our nation and for American families. For nearly ...ilosophy -- as far back as Teddy Roosevelt -- have...
(Date:11/7/2009)...d A. Cook (GA), Louis J. Goodman (TX), Palmer P. J...CAGO, Nov. 7 The Americ...medical society executive leaders with achievement...and ideals of the medical profession. The awards w...ng meeting in Houston. ,, (Logo: http://www....
(Date:11/7/2009)...SNewswire/ -- With the final House vote on healthc...ing the entire bill hostage to further their antia...o far beyond the status quo restrictions on aborti...ll. In an outrageous amendment, which is expected...ce Democrats are demanding explicit and unequivoca...
(Date:11/7/2009)...SNewswire/ -- Speaker Nancy Pelosi and Democratic ...ollowing a Democratic Whip meeting with President ...eaker,s opening remarks: ,, "Thank you very mu... to receive the President of the United States on ...ote and making progress for the American people. ...
Breaking Medicine News(10 mins):Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:AMA Honors Medical Society Executives 2Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2
...Scrip,s new Pharmaceutical Company,League Tables, ...ace behind,Johnson &Johnson (J&J) in the list of c...ss divisions. Only 43% of J&J,s revenue comes fro...gh operating conditions in 2006 -,caused by patent...
...espite widespread belief among cancer patients and...relieve nausea caused by cancer treatment, new res...he study, presented today (Wednesday) at the Europ...ctive acupuncture or a sham treatment that involve...
...h metastatic breast cancer who have also endured p...ncer recur nearly twice as fast as other women, ac...edical Center scientist. , The small, retrospec...pared with women who have more peaceful lives, who...
... Quality and Convenience Close to Home and the ..., Sept. 26 MinuteClinic,( http://www.minuteclinic...-,based health care in the United States, has open...the area by the end of,the year. MinuteClinic hea...
.... 26 Milestone,Scientific, Inc. (OTC Bulletin Boa...tion technologies, today announced that senior off...g EdgeWater Research Fall 2007,Small/Micro Cap Con...EN: Wednesday, October 10, 2007 at 8:50 AM MDT, ...
...er danger, but doses must be very high , ,... doses of caffeine and acetaminophen (such as Tyle...researchers warn. , This combo produces a byproduc... while taking acetaminophen, the experts added, bu...
Other Medicine News:Health News:Johnson & Johnson Tops Annual Pharmaceutical Company Rankings in a New Report From Industry-Leading Publication Scrip 2Health News:Acupuncture does not reduce radiotherapy-induced nausea, but patients believe it does 2Health News:Got stress? It could impact breast cancer recurrence 2Health News:An Innovation in Health Care Opens at CVS/pharmacy Stores in Pittsburgh 2Health News:An Innovation in Health Care Opens at CVS/pharmacy Stores in Pittsburgh 3Health News:An Innovation in Health Care Opens at CVS/pharmacy Stores in Pittsburgh 4Health News:Milestone Scientific to Present at the Edgewater Research Investor Conference 2Health News:Caffeine Plus Acetaminophen Toxic for Some 2
(Date:11/6/2009)... 6 Philips Respironics applauds th...revention (CDC) to raise awareness about an import...ency. The CDC,s release of the first-ever governme...sleeplessness is a milestone in quantifying the si... educator, industry leader and sleep therapy manuf...
(Date:11/6/2009)...ewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nas...he development of small-molecule therapeutics for ...ciency virus (HIV), today reported recent accompli...r and nine months ended September 30, 2009. ,,...1104/ARDEALOGO ) ,, "Since our last quarterly u...
(Date:11/6/2009)..., N.C., Nov. 6 Chimerix, Inc., a b...e antiviral therapeutics to address life-threateni...of the company,s lead antiviral compound, CMX001, ...bal Health Security Initiative (GHSI). CMX001 is ...or the treatment of smallpox, as well as other ser...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3NeurogesX and Astellas Enter Commercialization Agreement for Qutenza 28TM 29 49578 1NeurogesX and Astellas Enter Commercialization Agreement for Qutenza 28TM 29 49578 2NeurogesX and Astellas Enter Commercialization Agreement for Qutenza 28TM 29 49578 3NeurogesX and Astellas Enter Commercialization Agreement for Qutenza 28TM 29 49578 4NeurogesX and Astellas Enter Commercialization Agreement for Qutenza 28TM 29 49578 5NeurogesX and Astellas Enter Commercialization Agreement for Qutenza 28TM 29 49578 6Inspiration for My Sisters Keeper Speaks Out 4622 1Inspiration for My Sisters Keeper Speaks Out 4622 2Taiwans Science 26 Technology Policy Research and Information Center 28STPI 29 and Thomson Reuters Sign MOU of Collaboration to Support Science 26 49570 1Taiwans Science 26 Technology Policy Research and Information Center 28STPI 29 and Thomson Reuters Sign MOU of Collaboration to Support Science 26 49570 2Taiwans Science 26 Technology Policy Research and Information Center 28STPI 29 and Thomson Reuters Sign MOU of Collaboration to Support Science 26 49570 3
...AN MATEO, Calif., Oct. 3 Anthera Pharmaceuticals,...eveloping,anti-inflammatory therapeutics for chron... the completion of enrollment and patient dosing i..., A-002 for stable coronary,artery disease. Data a...,the year. "We are pleased with the rapid enrollm...
...DMONTON, Alberta, Oct. 2 Medical Services,Interna...ounce that the,demand for its VScan Dengue Fever K... Latin America and the Caribbean in one of the wor...in for hundreds of thousands,of people and killing...0,356 cases have been reported in the Americas and...
Other Medicine Technology:Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease 2Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease 3Demand for VScan Dengue Fever Test Kits Increases 2
... Laparofan™ single-use laparoscopic fan retr...y. It is indicated for endoscopic surgery and may ...Laparofan™ single-use V-shaped laparoscopic ...n with the Auto Suture™ Laparolift™ ar...
ENDO RETRACT™ Maxi 10 mm Retractor
Curved Fan Retractor
Articulating Fan Retractor
Medicine Products: